SCHEMBL8556763

SCHEMBL8556763

CCC(CN1CCCCC1)N(C)S(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ MAPT P10636 2/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ MITF O75030 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.52
▸ LMNA P02545 3/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ HTR2C P28335 7/20 0.51
▸ MCOLN3 Q8TDD5 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ PKM P14618 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ HTR6 P50406 5/20 0.43
▸ HTR2A P28223 4/20 0.43
▸ DRD3 P35462 4/20 0.43
▸ HTR1A P08908 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8557740 0.80 SLC6A9 (0.53) MEN1KMT2AHTR2CHTR6HTR2A
SCHEMBL8595287 0.79 HTR7 (0.54) HTTSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8595290 0.77 HTT (0.48) HTTSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL6338588 0.74 SIGMAR1 (0.62) HTTSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL14294227 0.72 NPC1 (0.56) HTTSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL8554824 0.69 SLC6A9 (0.51) MEN1KMT2AHTR2CHTR2AHTR7
SCHEMBL29212110 0.67 NPC1 (0.61) HTTSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL29964126 0.67 NPC1 (0.61) HTTSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL20021989 0.66 CNR2 (0.62) HTTSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL2832828 0.65 MEN1 (0.55) HTTSMN1; SMN2MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0883613-A1 SULFONAMIDE DERIVATIVES AS 5HT7 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-12-16 — — EP claimed
WO-1997029097-A1 SULFONAMIDE DERIVATIVES AS 5HT7 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-08-14 — — WO claimed
EP-0883613-A1 SULFONAMIDE DERIVATIVES AS 5HT7 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-12-16 — — EP disclosed
WO-1997029097-A1 SULFONAMIDE DERIVATIVES AS 5HT7 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-08-14 — — WO disclosed
Send feedback